ITT (ITT) Tops Q3 Earnings and Revenue Estimates — Positive
ITT Zacks Investment Research — October 29, 2025ITT (ITT) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.46 per share a year ago.
NiSource (NI) Misses Q3 Earnings Estimates — Negative
NI Zacks Investment Research — October 29, 2025NiSource (NI) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.2 per share a year ago.
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates — Positive
CVS Zacks Investment Research — October 29, 2025CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.
United Therapeutics (UTHR) Beats Q3 Earnings Estimates — Positive
UTHR Zacks Investment Research — October 29, 2025United Therapeutics (UTHR) came out with quarterly earnings of $7.16 per share, beating the Zacks Consensus Estimate of $6.89 per share. This compares to earnings of $6.39 per share a year ago.
Smurfit Westrock (SW) Q3 Earnings Miss Estimates — Negative
SW Zacks Investment Research — October 29, 2025Smurfit Westrock (SW) came out with quarterly earnings of $0.58 per share, missing the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.48 per share a year ago.
Apple suppliers Qorvo and Skyworks to merge, creating a $22 billion chip giant — Positive
AAPL QRVO SWKS Fast Company — October 29, 2025Apple suppliers Skyworks Solutions and Qorvo will merge in a cash-and-stock deal to create a radio chip company with an enterprise value of $22 billion.
YieldMax Semiconductor Portfolio Option Income ETF offers weekly distributions by writing covered calls on a diversified portfolio of semiconductor stocks. CHPY's structure enables investors to systematically harvest gains, amortize cost basis, and manage market timing anxiety in a volatile sector. While CHPY trails SOXX and SMH in total returns during up markets, its frequent payouts and overlap in holdings make it a compelling alternative.
Chart of the Day: NVDA Nears $5 Trillion Market Cap — Positive
NVDA Schwab Network — October 29, 2025Following several key partnerships and initiatives after its latest GTC event, Nvidia (NVDA) shares have become a "rocket ship" and are testing a $5 Trillion market cap. Rachel Dashiell examines Nvidia's technical patterns taking shape ahead of Wednesday's open.
Microsoft CEO Satya Nadella to visit India in December, sources say — Neutral
MSFT Reuters — October 29, 2025Microsoft chief executive Satya Nadella is set to travel to India in December, his second visit to the South Asian country this year where he plans to hold meetings with top government officials, two sources with direct knowledge said.
Boeing reported 3rd- quarter earnings and beat on revenue but missed on earnings.
NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Rise Ahead of FOMC — Positive
IVV SPLG SPXL SPY SSO UPRO VOO FXEmpire — October 29, 2025U.S. indices continue to push higher ahead of the FOMC decision, with the NASDAQ breaking out of its channel and the Dow approaching 48,000. Despite potential volatility around the Fed announcement, any short-term pullbacks are seen as buying opportunities within a firmly bullish trend.
Nasdaq expected to lead gains again as Trump talks up Nvidia chips pre Xi meeting — Positive
NVDA Proactive Investors — October 29, 2025US stocks are expected to climb to further heights on Wednesday, ahead of a key round of big tech earnings and an expected Federal Reserve interest rate cut. Futures for the Nasdaq 100 were up 0.5%, while those for the S&P 500 and Dow Jones gained 0.3% and 0.1% respectively.
Medicus Pharma, Gorlin Syndrome Alliance partner to expand SKINJECT access — Positive
MDCX Proactive Investors — October 29, 2025Medicus Pharma (NASDAQ:MDCX) has partnered with the Gorlin Syndrome Alliance (GSA) to expand compassionate access to its investigational microneedle therapy, SKINJECT, for patients suffering from Gorlin Syndrome, a rare genetic condition that causes recurring skin cancers. Under the collaboration, the two groups will pursue an Expanded Access Investigational New Drug (IND) program with the US Food and Drug Administration (FDA) to allow patients with multiple or inoperable basal cell carcinomas (BCCs) to receive SKINJECT under physician supervision.
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer — Neutral
PDSB GlobeNewsWire — October 29, 2025Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to be the most dominant type of head and neck cancer in the US by mid 2030s Proposed Amendment to Ongoing VERSATILE-003 Trial to include PFS Endpoint Based Upon Final VERSATILE-002 Trial Data Showing Robust Median Progression Free Survival of 6.3 months and Increased Median Overall Survival of 39.3 months PRINCETON, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and …
Why Boeing's commercial-airplanes business had another large loss even as revenue surged — Neutral
BA Market Watch — October 29, 2025Airplane deliveries rose and revenue surged while Boeing's defense and space business showed strength. But losses were wider than expected.
Banking giant sets Street-high price target for Apple stock — Positive
AAPL Finbold — October 29, 2025Apple (NASDAQ: AAPL) received a major boost from Bank of America, which raised its price target for the tech giant to $320 from $270, marking a new high among Wall Street forecasts.
Here Are Wednesday's Top Wall Street Analyst Research Calls: United Health, SoFi, Skyworks, Energy Transfer and More — Positive
ET SOFI SWKS UNH 24/7 Wall Street — October 29, 2025The futures are trading higher this morning after another stellar day across Wall Street on Tuesday, as all the major indices once again ended higher and continue to print new all-time highs.
Nvidia (NASDAQ: NVDA) Stock Price Prediction for 2025: Where Will It Be in 1 Year (Oct 29) — Positive
NVDA 24/7 Wall Street — October 29, 2025Shares of Nvidia Corp. (NASDAQ: NVDA) are up 13.7% over the past 90 days and poised to reach a $5 trillion valuation.
Alphabet Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call — Neutral
GOOG GOOGL Benzinga — October 29, 2025Alphabet Inc. (NASDAQ:GOOGL) will release earnings results for the third quarter, after the closing bell on Wednesday, Oct. 29.
Belite Bio to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 4th — Neutral
BLTE GlobeNewsWire — October 29, 2025Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com